Pontifax

Portfolio Companies 2026 for Pontifax: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Pontifax accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $1.5B. The median disclosed raise is $85M, and the largest is Crystalys Therapeutics at $205M, ahead of Abcuro ($200M) and Pairwise Plants ($180M).

The names that recur most often on these portfolio cap tables are Pontifax (13 companies), OrbiMed (3 companies), Novo Holdings (2 companies), abrdn Inc. (2 companies), Alexandria Venture Investments (2 companies), Foresite Capital (2 companies). By latest disclosed round, the market skews Series A (4), Series C (4), Series B (4).

Best funded Pontifax companies

  1. Crystalys Therapeutics — $205M (latest: Series A)
  2. Abcuro — $200M (latest: Series C)
  3. Pairwise Plants — $180M (latest: Series C)
  4. Anaveon — $156M (latest: Series B)
  5. V-Wave — $133M (latest: Series B)
  6. LB Pharmaceuticals — $130M (latest: Series C)
  7. Vanqua Bio — $85M (latest: Series B)
  8. StrideBio — $82M (latest: Series B)
  9. Keros Therapeutics — $79M (latest: Series C)
  10. Indapta Therapeutics — $73M (latest: Series A)
  11. 89bio — $60M (latest: Series A)
  12. Stargazer Pharmaceuticals — $57M (latest: Series A)
  13. LogicBio Therapeutics — $50M

Pontifax AgTech — related firms and companies (44)

Pontifax AgTech profile · All research reports